GEHC vs INCY: fair value comparison
GE HealthCare Technologies Inc. and Incyte Corporation · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, GEHC currently sits closer to the top of our discount ranking. INCY carries the stronger quality grade.
| GEHC | INCY | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $71.72 | $124.37 |
| 12-month range | $61.03–$82.82 | $85.98–$119.52 |
| Sector rank | #34 of 113 Healthcare | #35 of 113 Healthcare |
| Quality grade | F | A |
| Momentum grade | A | A |
| Leverage | Moderate | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: GEHC fair value analysis · INCY fair value analysis